Watch Ticker

PUMA BIOTECHNOLOGY INC

Go to PUMA BIOTECHNOLOGY INC Website

$3.18

-0.04 (-1.24%)

Live

Previous Close

$3.22

Day Range

$3.17 - $3.23

Previous Day Range

$3.045 - $3.25

Market Cap

$157.8 million USD

Day Vol.

11571

Previous Day Vol.

357515

Currency

USD

Primary Exchange

Nasdaq

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for t...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients

Er-Kim, an international pharmaceutical company, has signed an agreement with Puma Biotechnology to commercialize NERLYNX, a targeted therapy for early-stage HER2-positive breast cancer, in select countries in Eastern Europe and Central Asia.

Related tickers: PBYI.

Read Full Article

Investing.Com - Puma Biotechnology executive sells over $9,600 in stock - Investing.com

Puma Biotechnology's Chief Commercial Officer, Jeffrey Jerome Ludwig, sold 2,598 shares of the company's common stock for over $9,600. The sale was part of a pre-arranged trading plan, and Ludwig's direct ownership in the company now stands at 118,388 shares.

Related tickers: PBYI.

Read Full Article

Trending Tickers

Please sign in to view